RS
ZURA icon

R Squared’s Zura Bio ZURA Stock Holding History

R Squared’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,201
Closed -$10.7K – 733
2025
Q2 		$10.7K Buy
+10,201
New +$12.2K 0.01% 456

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

R Squared's ZURA Position: Q3 2025 in Review

R Squared sold out of Zura Bio (ZURA) in Q3 2025, closing a stake of 10,201 shares — an estimated $10.7K sold.

R Squared first reported a position in ZURA in Q2 2025 and held it in 1 quarter. The position peaked at $10.7K in Q2 2025. 69 funds tracked by Wall St. Rank hold ZURA as of Q3 2025.

  • R Squared reported no remaining Zura Bio position as of Q3 2025 after selling out during the quarter.
  • R Squared sold 10,201 Zura Bio shares in Q3 2025, an estimated $10.7K.
  • R Squared first reported a position in Zura Bio in Q2 2025 and held it in 1 quarter.
  • R Squared's Zura Bio position peaked at $10.7K in Q2 2025.
  • 69 funds tracked by Wall St. Rank held Zura Bio as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.